Save your place

Sign in to WhoBought

Please try again later.

Invesco's Bright Minds Biosciences Inc. (DRUG) position

Yes: as of Q1 2026, Invesco holds 6K shares of DRUG worth an amount we cannot price (0.0% of the disclosed portfolio). Last quarter the position was increased by 50.0%. First disclosed Q4 2025.
View full portfolio →
Current value
an amount we cannot price
Shares held
6K
% of portfolio
0.0%
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

DRUG price vs Invesco's position

1Y 3Y 5Y MAX
Dates
$74$74.5$75$75.5$76$76.5← Earlier —2 purchases
Average closing price · filing quarter
—
Price range · filing quarter
—
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Added +2K – +50.0% 6K May 12, 2026
Q4 2025 New +4K – – 4K Feb 19, 2026
Data through Q1 2026 · filed May 12, 2026
2 grouped rows from 2 quarters

More Invesco positions

NVIDIA Corporation(NVDA)
$24.7B
3.8% of portfolio

Apple Inc.(AAPL)
$18.4B
2.8% of portfolio

Microsoft Corporation(MSFT)
$15.7B
2.4% of portfolio

Alphabet Inc.(GOOGL)
$12.9B
2.0% of portfolio

Amazon.com, Inc.(AMZN)
$11.8B
1.8% of portfolio

Broadcom Inc.(AVGO)
$10.3B
1.6% of portfolio

Common questions

Does Invesco own DRUG?

Yes. As of Q1 2026, Invesco disclosed 6K shares of DRUG, worth an amount we cannot price. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Invesco buy DRUG?

Invesco first disclosed a DRUG position in Q4 2025; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Invesco sell DRUG?

The quarter-by-quarter table above shows each sale and reduction Invesco disclosed in DRUG. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of DRUG does Invesco own?

Invesco disclosed 6K shares of DRUG as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Invesco pay for DRUG?

Invesco began building the DRUG position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.